<?xml version='1.0' encoding='utf-8'?>

<rss version="2.0">
  <channel>
    <title>The Federal Register</title>
    <link>http://thefederalregister.com/b.p/agency/Food_and_Drug_Administration/2007-12-05/</link>
    <description>Daily Publications of Meetings and Rules Changes for the Federal Government</description>
    <pubDate>Sun, Nov 23 2008 11:00:00 GMT</pubDate>
    <lastBuildDate>Sun, Nov 23 2008 11:00:00 GMT</lastBuildDate>
    <webMaster>info@thefederalregister.com</webMaster>
    <item>
  <title><![CDATA[  Oral Dosage Form New Animal Drugs; Carprofen ]]></title>
  <link>http://thefederalregister.com/d.p/2007-12-05-E7-23516</link>
  <description><![CDATA[ The Food and Drug Administration (FDA) is amending the [[Page 68478]]<br/>
animal drug regulations to reflect approval of an original abbreviated 
new animal drug application (ANADA) filed by Belcher Pharmaceuticals, 
Inc. The ANADA provides for veterinary prescription use of carprofen 
caplets in dogs.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2007-12-05-E7-23516</guid>
  <pubDate>Wed, Dec 5 2007 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  New Animal Drugs For Use in Animal Feeds; Monensin ]]></title>
  <link>http://thefederalregister.com/d.p/2007-12-05-E7-23519</link>
  <description><![CDATA[ The Food and Drug Administration (FDA) is amending the animal 
drug regulations to reflect approval of a supplemental new animal drug 
application (NADA) filed by Elanco Animal Health. The supplemental NADA 
revises the concentration of monensin in twoway Type B and Type C 
medicated feeds containing monensin and tylosin to cattle fed in 
confinement for slaughter and a revision to bacterial pathogen 
nomenclature.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2007-12-05-E7-23519</guid>
  <pubDate>Wed, Dec 5 2007 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  New Animal Drugs For Use in Animal Feeds; Monensin USP ]]></title>
  <link>http://thefederalregister.com/d.p/2007-12-05-E7-23517</link>
  <description><![CDATA[ The Food and Drug Administration (FDA) is amending the animal 
drug regulations to reflect approval of a supplemental new animal drug 
application (NADA) filed by Elanco Animal Health. The supplemental NADA 
removes the requirement for 30day expiration on labeling of monensin 
Type C medicated feeds for several classes of cattle and goats.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2007-12-05-E7-23517</guid>
  <pubDate>Wed, Dec 5 2007 11:00:00 GMT</pubDate>
</item>
</channel>
</rss>

